Mclean Hospital

Roger Weiss Related Content


Philanthropy Provides Crucial Support for Addiction Treatment

When Maria Curtis’s son was released from a McLean treatment program, she was so impressed by the follow-up he received that she and her husband John made a gift to the hospital, directing it to help patients during their early recovery. Their generosity was enormously appreciated, says Roger D. Weiss, MD, chief of McLean’s Center of Excellence in Substance Use Disorders. Dr. Weiss...

McLean Staff Discuss Mental Health With Senator Angus King of Maine

Roger D. Weiss, MD, chief of McLean Hospital’s Substance Use Disorders Division; Adriana Bobinchock, senior director of Public Affairs and Communications at McLean; and Christine Tebaldi, PMHNP-BC, director of Clinical Business Development at McLean, joined Maine Senator Angus King this past July for a discussion about the opiate crisis, access to mental health care, and the stigma that too...

On the Front Line of the Opioid Crisis: McLean Takes Action

It was a problem we never used to speak about, something that afflicted those “down on their luck” or residents of “skid row” who could not cope with their lives. They dealt with those challenges with alcohol and drug abuse, the drug of choice frequently heroin. Today, addiction—particularly to opiates like heroin and synthetic opioids like oxycodone and fentanyl...

McLean’s Integrated Group Therapy App Wins Innovation Challenge

A team from McLean Hospital won this year’s Partners Connected Health Innovation Challenge (CHIC) for a proposal to create a digital platform that brings integrated group therapy (IGT) to individuals with co-occurring mood disorders and addiction to drugs or alcohol. The team, which competed against more than 50 other submissions, will receive 200 hours of service from the Partners...

The Consequences of Marijuana Legalization: A Behavioral and Mental Health Perspective

As clinicians and researchers at McLean Hospital, where we see individuals who have problems with marijuana use as well as other mental health conditions, we would like to provide information about the adverse health consequences of marijuana and its legalization for recreational use. The legalization of marijuana for recreational use is proposed in Ballot Question 4. We believe that a “yes...

Q & A: Roger Weiss, MD, Chief of the Center of Excellence in Substance Use Disorders

The abuse of alcohol, prescription medications, and illegal drugs is one of the most serious health problems in the United States. Substance use disorders have devastating effects on families and communities and their cost to society is immeasurable. McLean’s Center of Excellence in Substance Use Disorders fosters integrated, evidence-based approaches to prevention, early detection, and...

McLean Set to Launch Substance Abuse Program in Camden, Maine

McLean Borden Cottage, scheduled to open in early 2015 in Camden, Maine, is the hospital’s new residential treatment program for drug and alcohol addiction and the first McLean program to open outside of Massachusetts. Set on nearly 14 acres of lawns and gardens and overlooking Penobscot Bay, Borden Cottage is modeled clinically after McLean’s other off-campus programs and will be...

McLean Hospital’s Roger Weiss Earns Hazelden’s Dan Anderson Research Award

Roger D. Weiss, MD, chief of McLean Hospital’s Division of Alcohol and Drug Abuse, has been selected as the 2012 recipient of the Hazelden Foundation’s Dan Anderson Research Award. Sponsored by the Butler Center for Research at Hazelden, the Dan Anderson Research Award recognizes a single published article by a researcher who has advanced the scientific knowledge of addiction recovery...

Seeing Beyond The Data: McLean-Led National Study Informs Clinical Care Methods

Chief of the Division of Alcohol and Drug Abuse, Roger D. Weiss, MD, has long been a leader in the field of substance abuse treatment, research, and education. It was no surprise when he was tapped by the National Institute of Drug Abuse (NIDA) to lead the first large-scale study to address treatment of prescription opioid addiction. The results of the six-year study, announced in the December...

Suboxone is Most Effective in Treating Painkiller Addiction

Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in today's online edition of the Archives of General Psychiatry (doi: 10.1001/archgenpsychiatry.2011.121). “Adjunctive Counseling During Brief and Extended Buprenorphine-...

Making Connections: Divisions Advance McLean’s Strategic Agenda

When Bill and Barbara Boger learned of plans for a Division of Psychotic Disorders at McLean, they saw an opportunity to make a lasting difference through their philanthropy. The Bogers, McLean National Council members and longtime donors, have contributed to many clinical and research endeavors at the hospital over the years, often helping new initiatives get their start. In 2009, they saw the...

Recovery in Residence: New Program Fills Gap in Addiction Treatment in the Region

In keeping with its strategic goal of extending services, the hospital has opened the McLean Residence at the Brook, a transitional living program for adults with substance use disorders. The eight-bedroom residence, located in a newly renovated Colonial in Waltham, Massachusetts, offers a structured, supportive home-like environment. With a minimum length of stay of 90 days, the private-pay...